About Company
Morepen Laboratories Limited is an Indian pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium, and Sultamicillin. The company markets its formulated products in various therapeutic categories such as antibiotics, gastrointestinal, respiratory, analgesics, antiallergy, and neuropsychiatry under the brand names Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen-DSR, and Montelast. The company has added new products in therapeutic categories including Kilbac, Ducal D, Aclomore, and Montelast-L. The company has three state-of-the-art manufacturing facilities in Himachal Pradesh (HP), North India.
The company is the global leader in loratadine (140 tons) and has become one of the largest suppliers of the anti-asthma drug montelukast sodium (85 tons). It is the main enterprise in the commercial production of atorvastatin calcium (120 tons), anti-hypercholesterol series rosuvastatin calcium, anti-histamine series fexofenadine hydrochloride, anti-hypertension series olmesartan and their intermediates.
Credit goes to: Screener
PROS
- The company has almost no debt
CONS
- Despite reporting profits on several occasions, the company does not pay dividends.
- The company's return on equity over the past three years is low at 12.3%.
Peer comparison
Credit goes to: Screener
Follow us on Twitter or X: Best Fundamentals Stock Analysis
The stock stands at its near-weekly breakout. If it breaks its resistance it may go to its next target. The current price is 55.71 INR. Stock goes through its continuously uptrend movement. Share makes the cup and handle pattern as well. Even this stock is fundamentally strong and almost deft-free. The price will go above 100 INR in the upcoming days.
Read More: BTC Neglects to Recover $62K, SOL and Dab Take off by 8% Everyday
